Samuel Ohiomokhare
The Pathopharmacological Interplay between Vanadium and Iron in Parkinson’s Disease Models
Ohiomokhare, Samuel; Olaolorun, Francis; Ladagu, Amany; Olopade, Funmilayo; Howes, Melanie-Jayne R.; Okello, Edward; Olopade, James; Chazot, Paul L.
Authors
Francis Olaolorun
Amany Ladagu
Funmilayo Olopade
Melanie-Jayne R. Howes
Edward Okello
James Olopade
Professor Paul Chazot paul.chazot@durham.ac.uk
Professor
Abstract
Parkinson’s disease (PD) pathology is characterised by distinct types of cellular defects, notably associated with oxidative damage and mitochondria dysfunction, leading to the selective loss of dopaminergic neurons in the brain’s substantia nigra pars compacta (SNpc). Exposure to some environmental toxicants and heavy metals has been associated with PD pathogenesis. Raised iron levels have also been consistently observed in the nigrostriatal pathway of PD cases. This study explored, for the first time, the effects of an exogenous environmental heavy metal (vanadium) and its interaction with iron, focusing on the subtoxic effects of these metals on PD-like oxidative stress phenotypes in Catecholaminergic a-differentiated (CAD) cells and PTEN-induced kinase 1 (PINK−1)B9Drosophila melanogaster models of PD. We found that undifferentiated CAD cells were more susceptible to vanadium exposure than differentiated cells, and this susceptibility was modulated by iron. In PINK−1 flies, the exposure to chronic low doses of vanadium exacerbated the existing motor deficits, reduced survival, and increased the production of reactive oxygen species (ROS). Both Aloysia citrodora Paláu, a natural iron chelator, and Deferoxamine Mesylate (DFO), a synthetic iron chelator, significantly protected against the PD-like phenotypes in both models. These results favour the case for iron-chelation therapy as a viable option for the symptomatic treatment of PD.
Citation
Ohiomokhare, S., Olaolorun, F., Ladagu, A., Olopade, F., Howes, M.-J. R., Okello, E., Olopade, J., & Chazot, P. L. (2020). The Pathopharmacological Interplay between Vanadium and Iron in Parkinson’s Disease Models. International Journal of Molecular Sciences, 21(18), Article 6719. https://doi.org/10.3390/ijms21186719
Journal Article Type | Article |
---|---|
Acceptance Date | Sep 8, 2020 |
Online Publication Date | Sep 14, 2020 |
Publication Date | 2020-09 |
Deposit Date | Sep 14, 2020 |
Publicly Available Date | Sep 15, 2020 |
Journal | International Journal of Molecular Sciences |
Print ISSN | 1661-6596 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 21 |
Issue | 18 |
Article Number | 6719 |
DOI | https://doi.org/10.3390/ijms21186719 |
Public URL | https://durham-repository.worktribe.com/output/1292337 |
Files
Published Journal Article (Supplementary information)
(375 Kb)
Archive
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
Supplementary information
Published Journal Article
(1.8 Mb)
PDF
Publisher Licence URL
http://creativecommons.org/licenses/by/4.0/
Copyright Statement
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access
article distributed under the terms and conditions of the Creative Commons Attribution
(CC BY) license (http://creativecommons.org/licenses/by/4.0/).
You might also like
Confidence of practitioners to support self-management of pain: A multidisciplinary survey
(2023)
Journal Article